Molecular Genetics of ApoC-II and Lipoprotein Lipase Deficiency
Apolipoprotein (apo) C-II plays a central role in normal triglyceride metabolism as cofactor for the enzyme lipoprotein lipase (LPL). Patients with a deficiency of either apoC-II or LPL have marked derangements in triglyceride metabolism which include an elevation of plasma triglycerides, fasting chylomicrons and VLDL (1). Clinical features of this syndrome, which is inherited as an autosomal recessive trait, include hepatosplenomegaly, eruptive xanthomas and an increased risk of pancreatitis. The diagnosis of apoC-II or LPL deficiency is established by finding a reduced post-heparin lipoprotein lipase activity which in apoC-II deficiency is corrected by the addition of normal apoC-II containing plasma.
KeywordsAutosomal Recessive Trait Lipoprotein Lipase Deficiency Eruptive Xanthoma Molony Murine Leukemia Virus Calcium Phosphate Coprecipitation Method
Unable to display preview. Download preview PDF.
- 1.J. D. Brunzell. in The Metabolic Basis of Inherited Disease, eds. C. R. Scriver, A. L. Sly, W. S. & D. Valle (McGraw-Hill. New York). 6th Ed.. 1165–1180 (1989).Google Scholar
- 6.O. U. Beg, M. S. Meng, S. I. Skarlatos, L. Previato, J. D. Brunzell, H. B. Brewer Jr., and S. S. Fojo, Proc. Natl. Acad. Sci. USA. In press.Google Scholar
- 9.T. Maniatis, E. F. Fritsch, and J. Sambrook, in A Laboratory Manual (Cold Spring Harbor Lab., Cold Spring Harbor, NY), Mol. Clon. 229–246.Google Scholar